Jiafeng Zou

571 citations
22 papers · 453 indexed · h-index 12
Topics
Nanoplatforms for cancer theranostics (10 papers)RNA Interference and Gene Delivery (4 papers)Gold and Silver Nanoparticles Synthesis and Applications (4 papers)
Partner nations
ChinaSwitzerland

In The Last Decade

Jiafeng Zou

22 papers receiving 448 citations

Peers

Jiafeng Zou
Comparison fields: 5 of 82
  • Biomedical Engineering 169
  • Biomaterials 150
  • Molecular Biology 126
  • Pharmaceutical Science 94
  • Materials Chemistry 68
Replace Minyi Lei with:
Minyi Lei China
Lingran Du China
Zhiyong Qian China
Shoko Itakura Japan
Qingzhi Lv China
Mahak Fatima India
Guy Yealland Germany
Hangsheng Zheng China
Xiyou Du China
Martina Di Francesco Italy
Jiafeng Zou relative to Minyi Lei China Minyi Lei's profile →
Citations per field
00.5×4.4×
Minyi Lei · 1×
Citations per year

Countries citing papers authored by Jiafeng Zou

Since Specialization
Citations

This map shows the geographic impact of Jiafeng Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiafeng Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiafeng Zou more than expected).

Fields of papers citing papers by Jiafeng Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiafeng Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiafeng Zou. The network helps show where Jiafeng Zou may publish in the future.

Co-authorship network of co-authors of Jiafeng Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Jiafeng Zou. A scholar is included among the top collaborators of Jiafeng Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiafeng Zou. Jiafeng Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 3
3 13
4 13
5 4
6 11
7 6
8 9
9 37
10 14
11 3
12 13
13 2
14 35
15 40
16 65
17 7
18 54
19 16
20 70

About Jiafeng Zou

Jiafeng Zou is a scholar working on Pharmaceutical Science, Biochemistry and Biomedical Engineering, having authored 22 papers that have together received 453 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (10 papers), RNA Interference and Gene Delivery (4 papers) and Gold and Silver Nanoparticles Synthesis and Applications (4 papers). The work is most often cited by research in Pharmaceutical Science (94 citations), Biomaterials (150 citations) and Biomedical Engineering (169 citations). Jiafeng Zou has collaborated with scholars based in China and Switzerland. Frequent co-authors include Hongyue Zheng, Fanzhu Li, Zhihong Zhu, Rui Ma, Ji‐Gang Piao, Feng Gao, Xiaojie Chen, Ke Zhang, Jingjing Zhu and Minbo Lan. Their work appears in journals such as Chemical Engineering Journal, Biochemical and Biophysical Research Communications and ACS Applied Materials & Interfaces.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026